Stocks
Axsome Therapeutics (AXSM) P/FCF US GAAP (year values) |
|||||||||
| FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | LTM ? | CAGR 5 years ? | |||
| P/FCF | -13.1 | 0.00 | 0.00 | -31.5 | -96.8 | -121.9 | |||
| Changes by years, y/y, % | -66% | -100% | +207% | +20.2% | |||||
Axsome Therapeutics. P/FCF
Axsome Therapeutics. P/FCF, changes, %
Axsome Therapeutics (AXSM) P/FCF US GAAP (quarter values) |
||||||||
| FY2025Q1 | FY2025Q2 | FY2025Q3 | FY2025Q4 | FY2026Q1 | LTM ? | |||
| P/FCF | -48.1 | -42.7 | -59.9 | -98.5 | -121.9 | -121.9 | ||
| Changes by years, y/y, % | +84% | +208% | +154% | |||||
| Changes by quarters, q/q, % | +50% | -11% | +40% | +64% | +24% | |||
